Slade Cecconi, Diamondbacks earn 5
SAN FRANCISCO (AP) — Right-hander Slade Cecconi held the San Francisco Giants to two runs in six innings in his 2024 debut, and Gabriel Moreno hit a two-run, go-ahead single in the sixth inning to lead the Arizona Diamondbacks to a 5-3 victory Sunday.
Cecconi (1-0) started in place of an injured Merrill Kelly to help the Diamondbacks earn a split of the four-game series. He was recalled from Triple-A Reno to make his fifth career start to replace Kelly, who was scratched with a shoulder injury.
Most Diamondbacks came to the park unaware they would not be playing behind Kelly, the team’s No. 2 starter. Cecconi flew in from Reno on Saturday night and was not told he was starting until a few hours before the game. Manager Torey Lovullo said that made Cecconi’s performance, and the team’s reaction to the injury news, more impressive.
“It was not an easy day,” Lovullo said. “You wake up and get the news on Merrill. It takes a toll on the team. And then what Slade did just kind of gave us a chance to catch our breath, and we won a big game.”
Related articles
Adams, Reyna, Turner, Ream are US concerns ahead of Copa America
NEW YORK (AP) — Tyler Adams, Gio Reyna, Matt Turner and Tim Ream will be given the three weeks ahead2024-05-21Free child care from higher taxes? These cities subsidize daycare
NEW ORLEANS (AP) — Last summer, Derrika Richard felt stuck. She didn’t have enough money to afford c2024-05-21- Police moved in to clear dozens of protesters who had set up tents in a courtyard at the Sorbonne Un2024-05-21
Ahead of the Paris Olympics, police clear a migrant camp near City Hall
PARIS (AP) — French police evicted migrants from a makeshift tent-camp next to Paris City Hall early2024-05-21'The Apprentice,' about a young Donald Trump, premieres in Cannes
CANNES, France (AP) — While Donald Trump’s hush money trial entered its sixth week in New York, an o2024-05-21US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the b2024-05-21
atest comment